O-RADS US v2022: an update from the American College of radiology's ovarian-adnexal reporting and data system US committee
LM Strachowski, P Jha, CH Phillips… - Radiology, 2023 - pubs.rsna.org
First published in 2019, the Ovarian-Adnexal Reporting and Data System (O-RADS) US
provides a standardized lexicon for ovarian and adnexal lesions, enables stratification of …
provides a standardized lexicon for ovarian and adnexal lesions, enables stratification of …
Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and …
B Van Calster, K Van Hoorde, L Valentin, AC Testa… - Bmj, 2014 - bmj.com
Objectives To develop a risk prediction model to preoperatively discriminate between
benign, borderline, stage I invasive, stage II-IV invasive, and secondary metastatic ovarian …
benign, borderline, stage I invasive, stage II-IV invasive, and secondary metastatic ovarian …
Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group
D Timmerman, B Van Calster, A Testa, L Savelli… - American journal of …, 2016 - Elsevier
Background Accurate methods to preoperatively characterize adnexal tumors are pivotal for
optimal patient management. A recent metaanalysis concluded that the International …
optimal patient management. A recent metaanalysis concluded that the International …
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
RG Moore, DS McMeekin, AK Brown, P DiSilvestro… - Gynecologic …, 2009 - Elsevier
INTRODUCTION: Patients diagnosed with epithelial ovarian cancer (EOC) have improved
outcomes when cared for at centers experienced in the management of EOC. The objective …
outcomes when cared for at centers experienced in the management of EOC. The objective …
The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
RG Moore, AK Brown, MC Miller, S Skates… - Gynecologic …, 2008 - Elsevier
OBJECTIVES.: The CA125 tumor marker is used to help predict the presence of ovarian
cancer in patients with an adnexal mass. Because elevated CA125 levels occur in many …
cancer in patients with an adnexal mass. Because elevated CA125 levels occur in many …
Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s
HE Karim-Kos, E de Vries, I Soerjomataram… - European journal of …, 2008 - Elsevier
INTRODUCTION: We present a comprehensive overview of most recent European trends in
population-based incidence of, mortality from and relative survival for patients with cancer …
population-based incidence of, mortality from and relative survival for patients with cancer …
ESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: an update
R Forstner, I Thomassin-Naggara, TM Cunha… - European …, 2017 - Springer
An update of the 2010 published ESUR recommendations of MRI of the sonographically
indeterminate adnexal mass integrating functional techniques is provided. An algorithmic …
indeterminate adnexal mass integrating functional techniques is provided. An algorithmic …
Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass
RG Moore, MC Miller, P Disilvestro… - Obstetrics & …, 2011 - journals.lww.com
OBJECTIVE: It is often difficult to distinguish a benign pelvic mass from a malignancy and
tools to help referring physician are needed. The purpose of this study was to validate the …
tools to help referring physician are needed. The purpose of this study was to validate the …
Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts
K Huhtinen, P Suvitie, J Hiissa, J Junnila… - British journal of …, 2009 - nature.com
Human epididymal secretory protein E4 (HE4, also known as WAP four-disulphide core
domain protein 2) is a new promising biomarker for ovarian cancer but its specificity against …
domain protein 2) is a new promising biomarker for ovarian cancer but its specificity against …
Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass
RG Moore, M Jabre-Raughley, AK Brown… - American journal of …, 2010 - Elsevier
OBJECTIVE: We sought to compare the Risk of Malignancy Index (RMI) to the Risk of
Ovarian Malignancy Algorithm (ROMA) to predict epithelial ovarian cancer (EOC) in women …
Ovarian Malignancy Algorithm (ROMA) to predict epithelial ovarian cancer (EOC) in women …